(19)
(11) EP 3 285 767 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.05.2019 Bulletin 2019/21

(45) Mention of the grant of the patent:
20.03.2019 Bulletin 2019/12

(21) Application number: 16718885.3

(22) Date of filing: 22.04.2016
(51) International Patent Classification (IPC): 
A61K 31/437(2006.01)
 A61P 21/00(2006.01)
(86) International application number:
PCT/GB2016/051122
(87) International publication number:
WO 2016/170353 (27.10.2016 Gazette 2016/43)

(54)

TREATMENT OF PAIN

BEHANDLUNG VON SCHMERZEN

TRAITEMENT DE LA DOULEUR

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 24.04.2015 GB 201507048

(43) Date of publication of application:
28.02.2018 Bulletin 2018/09

(73) Proprietor: BenevolentAI Cambridge Limited
London W1T 5HD (GB)

(72) Inventors:
  • GONZALEZ, Isabel
    Cambridge Cambridgeshire CB22 3AT (GB)
  • PRITCHARD, Martyn
    Cambridge Cambridgeshire CB22 3AT (GB)
  • RICHARDSON, Peter
    Cambridge Cambridgeshire CB22 3AT (GB)

(74) Representative: Gill Jennings & Every LLP 
The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)


(56) References cited: : 
WO-A1-2010/031789
WO-A1-2015/159112
 WO-A1-2014/199171
US-A1- 2007 066 646
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).